Regulatory compliance with ANVISA (National Health Surveillance Agency) and MAPA (Ministry of Agriculture, Livestock and Supply) is a crucial step for product approval in the pharmaceutical, cosmetic, and food sectors. Meeting these requirements not only ensures consumer safety but also guarantees the commercial success of products. However, how can companies achieve this compliance more strategically, securely, and efficiently?
What is regulatory compliance?
Regulatory compliance means fully adhering to laws, technical standards, and requirements set by agencies such as ANVISA and MAPA. In Brazil, while ANVISA regulates medicines, cosmetics, sanitizers, and health products, MAPA is responsible for foods, beverages, pesticides, animal and plant products, among others.
This requirement covers all stages of product development: from formulation design to dossier submission, testing, and registration. Failure to meet these standards can result in sanctions, including product rejection, fines, or market withdrawal.
Common challenges companies face in regulatory compliance
Despite its importance, the Brazilian regulatory process is known for its complexity. Key challenges faced by companies include:
-
Preparation of extensive and detailed technical dossiers;
-
Requirement of robust scientific proof of safety, efficacy, and quality;
-
Frequent delays caused by incomplete documentation;
-
Difficulty in anticipating toxicological risks before laboratory testing.
Therefore, many companies have sought technological solutions to make this process faster and more predictable.
How technology can accelerate regulatory compliance with ANVISA and MAPA
Predictive computational analyses are transforming how products are developed and assessed. Through molecular modeling and in silico simulations, it is possible to predict critical properties of a compound early in the R&D phase.
Key predictions include:
- Pharmacokinetic properties – how the substance will be absorbed, distributed, metabolized, and excreted in the body.
- Toxicological profile – potential to cause adverse effects such as hepatotoxicity, mutagenicity, or carcinogenicity.
- Molecular interactions – helping estimate whether the product will be effective at its biological target.
Thanks to these predictions, high-risk molecules can be eliminated early, optimizing the development pipeline and building stronger dossiers for regulatory submission.
Moreover, according to ANVISA’s Guide for Regulatory Process Improvement Program (2022), the use of predictive data and alternative methods is encouraged, as it harmonizes Brazilian regulatory processes with international requirements from agencies such as the FDA (USA) and EMA (Europe).
DruGet’s contribution to the regulatory process
DruGet specializes in computational analyses applied to regulatory affairs. Its goal is to help companies anticipate risks, reduce animal testing, and accelerate product submissions to ANVISA and MAPA.
Through its proprietary platform, the company offers:
🔬 Prediction of toxicity, pharmacokinetics, and efficacy of molecules;
📁 Customizable technical reports for regulatory dossier submissions;
🌱 Solutions aligned with the 3Rs principles (Reduce, Refine, Replace), promoting sustainable innovation;
🤝 Specialized regulatory consulting focused on innovative products compliant with national and international standards.
As a result, DruGet’s clients achieve:
-
Significant reductions in regulatory submission time and costs;
-
Increased chances of approval by agencies;
-
Strengthened technical credibility of their dossiers.
Final considerations
Achieving regulatory compliance with ANVISA and MAPA is a complex but essential step for launching new products. Integrating predictive technologies and specialized consulting offers a real competitive advantage for companies aiming to innovate safely and responsibly.
If you want to accelerate your regulatory process and develop safer products, count on DruGet to turn challenges into opportunities.
References:
Anvisa. Guia para o Programa de Melhoria do Processo de Regulamentação. 2022. Disponível em: https://www.gov.br/anvisa
Medika. A Importância da Conformidade Regulatória e Certificações. 2025. Disponível em: https://medika.com.br/a-
